vs
Bank First Corp（BFC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Bank First Corp的1.6倍（$69.8M vs $44.9M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 45.8%，领先338.3%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 12.1%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 9.1%）
First Horizon Corporation（前身为田纳西第一银行）是一家成立于1864年、总部位于美国田纳西州孟菲斯的金融服务企业。通过旗下子公司First Horizon银行，其业务覆盖美国东南部12个州，是该区域第四大区域性银行。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BFC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.6倍
$44.9M
营收增速更快
RIGL
高出9.1%
12.1%
净利率更高
RIGL
高出338.3%
45.8%
两年增速更快
RIGL
近两年复合增速
9.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.9M | $69.8M |
| 净利润 | $18.4M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 51.0% | 33.2% |
| 净利率 | 45.8% | 384.0% |
| 营收同比 | 12.1% | 21.2% |
| 净利润同比 | 4.8% | 1769.2% |
| 每股收益（稀释后） | $1.87 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFCRIGL
| Q4 25 | $44.9M | $69.8M | ||
| Q3 25 | $44.2M | $69.5M | ||
| Q2 25 | $41.6M | $101.7M | ||
| Q1 25 | $43.1M | $53.3M | ||
| Q4 24 | $40.1M | $57.6M | ||
| Q3 24 | $40.8M | $55.3M | ||
| Q2 24 | $38.9M | $36.8M | ||
| Q1 24 | $37.7M | $29.5M |
净利润BFCRIGL
| Q4 25 | $18.4M | $268.1M | ||
| Q3 25 | $18.0M | $27.9M | ||
| Q2 25 | $16.9M | $59.6M | ||
| Q1 25 | $18.2M | $11.4M | ||
| Q4 24 | $17.5M | $14.3M | ||
| Q3 24 | $16.6M | $12.4M | ||
| Q2 24 | $16.1M | $-1.0M | ||
| Q1 24 | $15.4M | $-8.2M |
毛利率BFCRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率BFCRIGL
| Q4 25 | 51.0% | 33.2% | ||
| Q3 25 | 50.8% | 40.9% | ||
| Q2 25 | 49.7% | 60.1% | ||
| Q1 25 | 51.3% | 23.9% | ||
| Q4 24 | 54.4% | 28.9% | ||
| Q3 24 | 50.7% | 25.4% | ||
| Q2 24 | 51.0% | 1.2% | ||
| Q1 24 | 45.6% | -23.6% |
净利率BFCRIGL
| Q4 25 | 45.8% | 384.0% | ||
| Q3 25 | 40.7% | 40.2% | ||
| Q2 25 | 40.5% | 58.6% | ||
| Q1 25 | 42.3% | 21.5% | ||
| Q4 24 | 49.3% | 24.9% | ||
| Q3 24 | 40.6% | 22.5% | ||
| Q2 24 | 41.3% | -2.8% | ||
| Q1 24 | 40.8% | -27.9% |
每股收益（稀释后）BFCRIGL
| Q4 25 | $1.87 | $14.11 | ||
| Q3 25 | $1.83 | $1.46 | ||
| Q2 25 | $1.71 | $3.28 | ||
| Q1 25 | $1.82 | $0.63 | ||
| Q4 24 | $1.75 | $0.82 | ||
| Q3 24 | $1.65 | $0.70 | ||
| Q2 24 | $1.59 | $-0.06 | ||
| Q1 24 | $1.51 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $243.2M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $643.8M | $391.5M |
| 总资产 | $4.5B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BFCRIGL
| Q4 25 | $243.2M | $155.0M | ||
| Q3 25 | $126.2M | $137.1M | ||
| Q2 25 | $120.3M | $108.4M | ||
| Q1 25 | $300.9M | $77.1M | ||
| Q4 24 | $261.3M | $77.3M | ||
| Q3 24 | $204.4M | $61.1M | ||
| Q2 24 | $99.0M | $49.1M | ||
| Q1 24 | $83.4M | $49.5M |
总债务BFCRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益BFCRIGL
| Q4 25 | $643.8M | $391.5M | ||
| Q3 25 | $628.1M | $117.6M | ||
| Q2 25 | $612.3M | $81.9M | ||
| Q1 25 | $648.4M | $18.6M | ||
| Q4 24 | $639.7M | $3.3M | ||
| Q3 24 | $628.9M | $-14.6M | ||
| Q2 24 | $614.6M | $-29.9M | ||
| Q1 24 | $609.3M | $-31.7M |
总资产BFCRIGL
| Q4 25 | $4.5B | $513.6M | ||
| Q3 25 | $4.4B | $242.5M | ||
| Q2 25 | $4.4B | $206.7M | ||
| Q1 25 | $4.5B | $176.0M | ||
| Q4 24 | $4.5B | $164.0M | ||
| Q3 24 | $4.3B | $139.4M | ||
| Q2 24 | $4.1B | $128.4M | ||
| Q1 24 | $4.1B | $126.5M |
负债/权益比BFCRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $62.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $51.0M | — |
| 自由现金流率自由现金流/营收 | 113.6% | — |
| 资本支出强度资本支出/营收 | 25.5% | — |
| 现金转化率经营现金流/净利润 | 3.40× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $75.8M | — |
8季度趋势，按日历期对齐
经营现金流BFCRIGL
| Q4 25 | $62.5M | $22.0M | ||
| Q3 25 | $15.5M | $24.0M | ||
| Q2 25 | $11.9M | $30.5M | ||
| Q1 25 | $6.2M | $-893.0K | ||
| Q4 24 | $65.8M | $14.5M | ||
| Q3 24 | $18.8M | $21.7M | ||
| Q2 24 | $14.9M | $302.0K | ||
| Q1 24 | $1.3M | $-5.0M |
自由现金流BFCRIGL
| Q4 25 | $51.0M | — | ||
| Q3 25 | $12.5M | — | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | $4.0M | — | ||
| Q4 24 | $58.6M | — | ||
| Q3 24 | $16.9M | — | ||
| Q2 24 | $13.7M | — | ||
| Q1 24 | $551.0K | — |
自由现金流率BFCRIGL
| Q4 25 | 113.6% | — | ||
| Q3 25 | 28.2% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 146.3% | — | ||
| Q3 24 | 41.5% | — | ||
| Q2 24 | 35.3% | — | ||
| Q1 24 | 1.5% | — |
资本支出强度BFCRIGL
| Q4 25 | 25.5% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 18.0% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | 2.1% | — |
现金转化率BFCRIGL
| Q4 25 | 3.40× | 0.08× | ||
| Q3 25 | 0.86× | 0.86× | ||
| Q2 25 | 0.70× | 0.51× | ||
| Q1 25 | 0.34× | -0.08× | ||
| Q4 24 | 3.75× | 1.01× | ||
| Q3 24 | 1.13× | 1.75× | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 0.09× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
